Bert Benthem

Q: What is Bert Benthem email address?

Email Bert Benthem at bert.benthem@yahoo.se and benthembert@gmail.com. This email is the most updated Bert Benthem's email found in 2026.

Q: How to contact Bert Benthem?

To contact Bert Benthem send an email to bert.benthem@yahoo.se or benthembert@gmail.com. (updated on January 19, 2024)

Founder at Calthorne AB | Greater Gothenburg Metropolitan Area

About Bert Benthem

Bert Benthem serves as the Chief Scientific Officer and Co-Founder of INORBIT Therapeutics AB, where he leverages over three decades of extensive experience in metabolic research and drug development. His career has been marked by a commitment to addressing significant unmet medical needs, particularly in the realm of liver diseases and metabolic disorders such as Type 2 diabetes. At INORBIT, Bert is at the forefront of pioneering efforts to resurrect small molecule drugs that previously demonstrated human efficacy but were sidelined due to Drug-Induced Liver Injury (DILI). This innovative approach not only aims to revitalize promising compounds but also to enhance patient outcomes in therapeutic areas with high medical demand.

Bert's expertise in pharmacokinetics and his deep understanding of GPCRs (G-protein coupled receptors) play a crucial role in the strategic direction of INORBIT's unique chemistry platform. His leadership is characterized by a collaborative spirit, fostering cross-functional team dynamics that span multiple therapeutic areas and international borders. This global perspective is vital as INORBIT navigates the complexities of drug discovery and development, ensuring that projects are managed efficiently and effectively.

Under Bert's guidance, INORBIT Therapeutics is not just focused on reviving lost opportunities in drug development; it is also committed to advancing the science of metabolism and liver health. His vision for the company is to bridge the gap between innovative research and real-world applications, ultimately contributing to the advancement of biotechnology and pharmaceutical research. With a robust background in line management and project leadership, Bert Benthem continues to be a driving force in transforming the landscape of drug discovery, making significant strides toward improving therapies for patients worldwide.

Bert Benthem Work